rhCG

DRUG5 trials

Sponsors

University of Virginia, Chong Qing Reproducive and Genetic Institute, Mansoura University

Conditions

HyperandrogenemiaHyperandrogenismInfertilityObesityPolycystic Ovary Syndrome

Early Phase 1

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

WithdrawnNCT01422733

University of VirginiaHyperandrogenemia, Obesity, Polycystic Ovary Syndrome

Start: 2018-06-01End: 2018-07-17Updated: 2018-07-19

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

RecruitingNCT03905603

University of VirginiaPolycystic Ovary Syndrome

Start: 2019-10-08End: 2026-05-01Target: 144Updated: 2023-11-03

Unknown Phase

Ovarian Contribution to Androgen Production in Adolescent Girls

University of VirginiaHyperandrogenism, Obesity, Polycystic Ovary Syndrome

Start: 2011-03-10End: 2025-12-31Target: 80Updated: 2023-10-27

Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol

Chong Qing Reproducive and Genetic InstituteInfertility

Start: 2016-01-31End: 2017-03-31Target: 200Updated: 2015-12-21

HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

CompletedNCT05969834

Mansoura UniversityInfertility

Start: 2021-03-31End: 2022-08-07Updated: 2023-08-01

Related Papers

Fixed versus flexible antagonist protocol in women with predicted high ovarian response except PCOS: a randomized controlled trial.

2021-05-0211 citations